CD8A and neoplasm: The delivery of IL-12 via a self-amplifying RNA, derived from SFV intratumorally electroporated into mice, to treat MC38 subcutaneous colon and hepatocarcinoma tumors showed anti-tumor effects and the induction of CD8 T cells [128].